series-c-plus
Stage
2012
Founded
2
Investors
About
Inventiva is a clinical-stage biopharmaceutical company that develops oral small molecule therapies for diseases with significant unmet medical needs, including fibrosis, lysosomal storage disorders, and oncology. Its lead product, lanifibranor, is in Phase 3 clinical trials for metabolic dysfunction-associated steatohepatitis (MASH/NASH).
Explore Inventiva's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.